000			02358 a2200697 4500
005			20250513211930.0
264		0	_c20001103
008			200011s 0 0 eng d
022			_a1042-8194
024	7		_a10.3109/10428190009087024 _2doi
040			_aNLM _beng _cNLM
100	1		_aTomita, N
245	0	0	_aPredictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations. _h[electronic resource]
260			_bLeukemia & lymphoma _cJul 2000
300			_a335-43 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aBleomycin _xadministration & dosage
650	0	4	_aCentral Nervous System _xpathology
650	0	4	_aCombined Modality Therapy
650	0	4	_aCranial Irradiation
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aLife Tables
650	0	4	_aLymphoma, Non-Hodgkin _xclassification
650	0	4	_aMeninges _xpathology
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aNeoplasm Proteins _xblood
650	0	4	_aNeurologic Examination
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xadministration & dosage
700	1		_aKodama, F
700	1		_aSakai, R
700	1		_aKoharasawa, H
700	1		_aHattori, M
700	1		_aTaguchi, J
700	1		_aFujita, H
700	1		_aTanabe, J
700	1		_aFujisawa, S
700	1		_aFukawa, H
700	1		_aHarano, H
700	1		_aKanamori, H
700	1		_aMiyashita, H
700	1		_aMatsuzaki, M
700	1		_aOgawa, K
700	1		_aMotomura, S
700	1		_aMaruta, A
700	1		_aIshigatsubo, Y
773	0		_tLeukemia & lymphoma _gvol. 38 _gno. 3-4 _gp. 335-43
856	4	0	_uhttps://doi.org/10.3109/10428190009087024 _zAvailable from publisher's website
999			_c10782277 _d10782277